JPMorgan Chase & Co’s Vertex Pharmaceuticals VRTX Stock Holding History

JPMorgan Chase & Co’s Portfolio VRTX Stock Details VRTX Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$2.61B	Sell	5,869,361 -1,886,284	-24%	-$840M	0.17%	118
2025 Q1	$3.76B	Buy	7,755,645 +1,442,538	+23%	+$699M	0.27%	80
2024 Q4	$2.54B	Sell	6,313,107 -615,480	-9%	-$248M	0.19%	114
2024 Q3	$3.22B	Buy	6,928,587 +328,802	+5%	+$153M	0.24%	88
2024 Q2	$3.09B	Buy	6,599,785 +581,661	+10%	+$273M	0.25%	82
2024 Q1	$2.52B	Buy	6,018,124 +393,859	+7%	+$165M	0.21%	96
2023 Q4	$2.29B	Sell	5,624,265 -481,587	-8%	-$196M	0.22%	98
2023 Q3	$2.12B	Buy	6,105,852 +150,327	+3%	+$52.3M	0.23%	88
2023 Q2	$2.1B	Sell	5,955,525 -405,233	-6%	-$143M	0.23%	95
2023 Q1	$2B	Buy	6,360,758 +870,350	+16%	+$274M	0.24%	95
2022 Q4	$1.59B	Buy	5,490,408 +630,721	+13%	+$182M	0.21%	105
2022 Q3	$1.41B	Sell	4,859,687 -377,855	-7%	-$109M	0.2%	108
2022 Q2	$1.48B	Buy	5,237,542 +424,873	+9%	+$120M	0.21%	103
2022 Q1	$1.26B	Buy	4,812,669 +348,338	+8%	+$90.9M	0.15%	140
2021 Q4	$980M	Buy	4,464,331 +252,599	+6%	+$55.5M	0.11%	187
2021 Q3	$764M	Sell	4,211,732 -226,331	-5%	-$41.1M	0.09%	215
2021 Q2	$895M	Buy	4,438,063 +1,231,763	+38%	+$248M	0.11%	200
2021 Q1	$689M	Buy	3,206,300 +618,276	+24%	+$133M	0.09%	221
2020 Q4	$612M	Buy	2,588,024 +348,214	+16%	+$82.3M	0.09%	219
2020 Q3	$605M	Buy	2,239,810 +126,724	+6%	+$34.3M	0.1%	193
2020 Q2	$613M	Sell	2,113,086 -81,689	-4%	-$23.7M	0.12%	179
2020 Q1	$522M	Sell	2,194,775 -390,614	-15%	-$92.9M	0.12%	167
2019 Q4	$566M	Sell	2,585,389 -788,425	-23%	-$173M	0.11%	193
2019 Q3	$572M	Sell	3,373,814 -959,889	-22%	-$163M	0.11%	184
2019 Q2	$774M	Sell	4,333,703 -2,449,932	-36%	-$438M	0.15%	140
2019 Q1	$1.25B	Sell	6,783,635 -403,886	-6%	-$74.3M	0.25%	80
2018 Q4	$1.19B	Buy	7,187,521 +70,305	+1%	+$11.7M	0.28%	74
2018 Q3	$1.37B	Buy	7,117,216 +355,139	+5%	+$68.4M	0.26%	71
2018 Q2	$1.15B	Sell	6,762,077 -1,222,383	-15%	-$208M	0.24%	81
2018 Q1	$1.3B	Sell	7,984,460 -1,413,492	-15%	-$230M	0.28%	62
2017 Q4	$1.41B	Buy	9,397,952 +75,505	+0.8%	+$11.3M	0.3%	61
2017 Q3	$1.39B	Buy	9,322,447 +939,894	+11%	+$141M	0.31%	60
2017 Q2	$1.08B	Sell	8,382,553 -978,823	-10%	-$126M	0.25%	79
2017 Q1	$1.02B	Sell	9,361,376 -1,235,572	-12%	-$135M	0.23%	82
2016 Q4	$781M	Sell	10,596,948 -430,141	-4%	-$31.7M	0.19%	112
2016 Q3	$962M	Sell	11,027,089 -1,146,350	-9%	-$100M	0.24%	85
2016 Q2	$1.05B	Buy	12,173,439 +485,112	+4%	+$41.7M	0.26%	79
2016 Q1	$929M	Sell	11,688,327 -929,737	-7%	-$73.9M	0.24%	86
2015 Q4	$1.59B	Buy	12,618,064 +1,133,873	+10%	+$143M	0.4%	43
2015 Q3	$1.2B	Buy	11,484,191 +905,507	+9%	+$94.3M	0.32%	56
2015 Q2	$1.31B	Buy	10,578,684 +394,066	+4%	+$48.7M	0.31%	54
2015 Q1	$1.2B	Sell	10,184,618 -241,616	-2%	-$28.5M	0.27%	65
2014 Q4	$1.24B	Sell	10,426,234 -165,171	-2%	-$19.6M	0.28%	67
2014 Q3	$1.19B	Buy	10,591,405 +955,407	+10%	+$107M	0.28%	64
2014 Q2	$912M	Buy	9,635,998 +2,029,309	+27%	+$192M	0.23%	80
2014 Q1	$538M	Sell	7,606,689 -1,573,569	-17%	-$111M	0.15%	159
2013 Q4	$682M	Buy	9,180,258 +1,554,124	+20%	+$115M	0.19%	109
2013 Q3	$578M	Buy	7,626,134 +748,645	+11%	+$56.8M	0.17%	131
2013 Q2	$551M	Buy	+6,877,489	New	+$551M	0.18%	123